Pondicherry Journal of Nursing

Register      Login

VOLUME 14 , ISSUE 4 ( October-December, 2021 ) > List of Articles

REVIEW ARTICLE

Sleep, Immunity, and Its Impact on COVID Vaccination

Dhivya Narayanasamy, Renuka Kandasamy

Keywords : COVID vaccination, Immunity, Sleep

Citation Information : Narayanasamy D, Kandasamy R. Sleep, Immunity, and Its Impact on COVID Vaccination. 2021; 14 (4):88-90.

DOI: 10.5005/jp-journals-10084-13119

License: CC BY-NC 4.0

Published Online: 08-02-2022

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Coronaviruses are a large group of viruses that cause illness in humans and animals. The outbreak of coronavirus disease-2019 (COVID-19) was initially noticed in a seafood market in Wuhan, China, in mid-December 2019. A person who has had COVID-19 infection confirmed in the laboratory, regardless of clinical symptoms. The Pfizer-BioNTech COVID-19 vaccine, the Moderna COVID-19 vaccine, and the Janssen (Johnson and Johnson) COVID-19 vaccine have all been approved by the US Food and Drug Administration (FDA) for emergency use. The importance of getting enough good sleep for your immune system cannot be overstated. Sleep is essential for a healthy immune system, and as COVID-19 vaccines are distributed, it is critical that people get enough sleep to stay healthy, and to maintain optimal health, people must continue to prioritize their sleep. “Getting enough, high-quality sleep on a daily basis boosts the immune system and optimizes overall reaction to a vaccine.” Normal sleep after vaccination boosts the immune response against an invading antigen, according to studies, and this immunity-boosting effect of sleep is clinically significant. “Getting a good night\'s sleep before and after immunization may be beneficial.”


HTML PDF Share
  1. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19–11 March 2020. 2020. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020 [Retrieved March 5, 2021].
  2. U.S. Food and Drug Administration. Emergency use authorization for vaccines explained. 2020. Available from: https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained [Retrieved March 5, 2021].
  3. World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. n.d. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it [Retrieved March 5, 2021].
  4. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases, CDC. How COVID-19 spreads. Centers for Disease Control and Prevention; 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html [Retrieved March 3, 2021].
  5. U.S. Food and Drug Administration. Janssen COVID-19 vaccine. 2021. Available from: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19- vaccine [Retrieved March 3, 2021].
  6. Chung YH, Beiss V, Fiering SN, Steinmetz NF. COVID-19 vaccine frontrunners and their nanotechnology design. ACS Nano 2020;14(10):12522–12537. DOI: 10.1021/acsnano.0c07197. Available from: https://pubmed.ncbi.nlm.nih.gov/33034449/.
  7. U.S. Food and Drug Administration. Pfizer-BioNTech COVID-19 vaccine frequently asked questions. 2021. Available from: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/pfizer-biontech-covid-19-vaccine-frequently-asked-questions [Retrieved March 3, 2021].
  8. Bangaru S, Ozorowski G, Turner HL, Antanasijevic A, Huang D, Wang X, et al. Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate. Science 2020;370(6520):1089–1094. DOI: 10.1126/science.abe1502. Available from: https://pubmed.ncbi.nlm.nih.gov/33082295/.
  9. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases, CDC. SARS-CoV-2 variants. Centers for Disease Control and Prevention. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveillance/variant-info.html [Retrieved March 3, 2021].
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.